One third of these plans had limits on all anti-nausea drugs. Options can include granisetron, prochlorperazine, promethazine ...

Reported positive YTD 2024 Adjusted EBITDA of $1.4 million Company expects Q4 2024 Net Revenue in the range of $37 million - $43 million ZYNRELEF® (bupivacaine ...

granisetron Cardiopulmonary arrest Hospitalization 26 (01/20/2000) 66, M Droperidol 1.25 mg i.v. Blood pressure decreased, ventricular tachycardia Life threatening 27 (03/16/2000) Not provided ...

Get detailed information on Apomorphine, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company, announced today that the United States (U.S.) Food and Drug Administration (FDA) granted Orphan Drug Designation and Rare ...

The Company provided the above adjusted supplemental financial performance measures, which are considered "non-GAAP" financial measures under applicable SEC rules and regulations. These financial ...